New combo pill aims to slash heart risk in diabetes patients
NCT ID NCT07219602
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 22 times
Summary
This study tests whether a new daily pill (obicetrapib, alone or combined with ezetimibe) can lower bad cholesterol more than a placebo in 300 adults with type 2 diabetes or metabolic syndrome who are already on standard cholesterol treatment. Participants take the study drug for about 3 months while continuing their usual medications. The goal is to see if the drug safely reduces heart disease risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Burke Internal Medicine
RECRUITINGBurke, Virginia, 22015-2234, United States
-
Burke International Medicine DBA Manassas Clinical Research Center
RECRUITINGManassas, Virginia, 20110, United States
-
Central New York Clinical Research
RECRUITINGManlius, New York, 13104, United States
-
Centricity Research dba Lucas Research
RECRUITINGMorehead City, North Carolina, 28557, United States
-
Clinical Research Institute of Arizona
RECRUITINGSun City West, Arizona, 85375, United States
-
Clinical Trials of Texas dba Flourish Research
RECRUITINGSan Antonio, Texas, 78229, United States
-
East Coast Institute of Research LLC
RECRUITINGJacksonville, Florida, 32216, United States
-
East Coast Institute of Research LLC
RECRUITINGLake City, Florida, 32055, United States
-
Floridian Clinical Research
RECRUITINGMiami Lakes, Florida, 33016, United States
-
Floridian Clinical Research
RECRUITINGGreensboro, North Carolina, 27408, United States
-
Inspira Health - Internal Medicine Associates
RECRUITINGBridgeton, New Jersey, 08302, United States
-
Jefferson City Medical Group
RECRUITINGJefferson City, Missouri, 65109, United States
-
Juno Research LLC - Medical Center
RECRUITINGHouston, Texas, 77054, United States
-
Louisville Metabolic and Atherosclerosis Research Center (L-MARC)
RECRUITINGLouisville, Kentucky, 40213, United States
-
MD Medical Research
RECRUITINGOxon Hill, Maryland, 20745, United States
-
Montana Medical Research
RECRUITINGMissoula, Montana, 59808, United States
-
Scripps Health - Whittier Diabetes Institute
RECRUITINGLa Jolla, California, 92037, United States
-
Summit Research Group
RECRUITINGMunroe Falls, Ohio, 44262, United States
-
UF Health Jackson
RECRUITINGJacksonville, Florida, 32209, United States
-
Velocity Clinical Research
RECRUITINGDurham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.